Category: Hot Opportunities

Cyren Ltd. (CYRN) stock prices were up by 4.71% as of the market closing on September 24th, 2021. This brought the price per share up to USD$0.58 at the end of the trading day. Subsequent premarket fluctuations have seen the stock rise by 3.78%, bringing

VIZIO Holding Corp. (VZIO) has seen an incline of 5.52% in the aftermarket. However, the last trading session concluded at $19.56 with a decrease of 1.16%. fuboTV Brings Live Sports, News, and Entertainment to VZIO SmartCast VZIO announced on 9th September 2021 that it is

ImmunityBio Inc. (IBRX) stock prices were down by 9.36% as of the market closing on September 24th, 2021. This brought the price per share down to USD$10.26 at the end of the trading day. Subsequent aftermarket fluctuations have seen the stock rise by 9.75%, bringing

Youdao, Inc. (DAO) experienced an incline of 5.57% in the aftermarket. However, the last trading session closed at $11.84 with an increase of 9.34%. Second Quarter 2021 Unaudited Financial Results DAO announced second-quarter 2021 financial results on 31 August 2021. The total net revenues were

Acurx Pharmaceuticals, Inc. (ACXP) saw a decline of 5.82% in the aftermarket on Friday. However, the last trading session closed at 4.385 with a decline of 7.68%. ACXP Joins the Russell Microcap Index On 2nd September 2021, ACXP announces joining Russell Microcap Index. A one-year

Shares of the Molecular Data Inc. (MKD) stock rose in the Pre-market today on September 24, 2021. MKD stock price saw a push of 3.78% to reach $0.31 a share at the time of this writing. It seems that Molecular stock is continuing the rising

Uxin Limited (UXIN) saw a push of 9.46% in the premarket after the company reported unaudited the first quarter of the fiscal year 2022 results. However, the last trading session closed at $2.96 with an incline of 2.78%. First Quarter of Fiscal Year 2022 Results

Color Start Technology Co. Ltd. (CSCW) stock prices were down by 1.47% as of the market closing on September 23rd, 2021. This brought the price per share down to USD$0.87 at the end of the trading day. Subsequent premarket fluctuations have seen the stock rise

Minerva Neurosciences, Inc. (NERV) has seen a push of 6.52% in the premarket today. However, the last trading session closed at $1.84 with an incline of 9.52%. Appointment of Dr. Ramana Kuchibhatla as Senior Vice President and Head of Research & Development NERV announced the

In addiiGlycoMimetics, Inc. (GLYC) has seen an increase of 2.62% after GLYC announced Efficacy and Safety Data for GlycoMimetics’ Lead Investigational Drug Uproleselan. However, the last trading session closed at $2.29 with an incline of 3.15%. Efficacy and Safety Data for GlycoMimetics’ Lead Investigational Drug